Article
Impact of Mycobacterium tuberculosis RD1-locus on human primary dendritic cell immune functions.
Scientific reports - 25 Nov 2015
Etna Marilena P, Giacomini Elena, Pardini Manuela, Severa Martina, Bottai Daria, Cruciani Melania, Rizzo Fabiana, Calogero Raffaele, Brosch Roland, Coccia Eliana M
Abstract excerpt
Modern strategies to develop vaccines against Mycobacterium tuberculosis (Mtb) aim to improve the current Bacillus Calmette-Guerin (BCG) vaccine or to attenuate the virulence of Mtb vaccine candidates. In the present study, the impact of wild type or mutated region of difference 1 (RD1) variants on the immunogenicity of Mtb and BCG recombinants was investigated in human primary dendritic cells (DC). A comparative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
